US FDA v. COVID Mutants: Multi-Factorial Assessments Will Determine When Product EUAs Need To Change

 
• By Sarah Karlin-Smith
  
COVID gears (shutterstock)
FDA is conducting wide-ranging scenario planning to deal with virus changes • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet